Adolph C Bohnstedt

Title: Adolph C Bohnstedt: Innovator in Immunosuppression

Introduction

Adolph C Bohnstedt is a notable inventor based in Burlington, NJ (US), recognized for his contributions to the field of immunosuppression. With a total of six patents to his name, Bohnstedt has made significant advancements in the treatment of autoimmune diseases and transplant rejection.

Latest Patents

Bohnstedt's latest patents include innovative compounds such as 6-substituted 2-(benzimidazolyl)purine and purinone derivatives. These compounds are designed for the prevention and treatment of autoimmune diseases, inflammatory diseases, mast cell-mediated diseases, and transplant rejection. The general formulae of these compounds involve selections from groups including CX and nitrogen, with various options for A, such as H, (C-C) alkyl, heteroaryl, and aryl. Another significant patent involves 8-substituted 2-(benzimidazolyl)purine derivatives, which also target similar medical conditions with a focus on novel purines.

Career Highlights

Throughout his career, Bohnstedt has worked with prominent companies in the pharmaceutical industry, including Wyeth and Pharmacopeia Drug Discovery, Inc. His work has contributed to the development of critical therapies aimed at improving patient outcomes in immunological conditions.

Collaborations

Bohnstedt has collaborated with notable professionals in his field, including Celia Kingsbury and Michael J Ohlmeyer. These partnerships have likely enhanced the scope and impact of his research and innovations.

Conclusion

Adolph C Bohnstedt's work in immunosuppression has led to significant advancements in the treatment of various diseases. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific discovery.